Trexquant Investment’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,343
Closed -$407K 1891
2024
Q4
$407K Sell
11,343
-11,506
-50% -$430K ﹤0.01% 1341
2024
Q3
$866K Sell
22,849
-19,010
-45% -$781K 0.01% 1091
2024
Q2
$1.89M Buy
41,859
+33,516
+402% +$1.54M 0.03% 778
2024
Q1
$405K Buy
8,343
+3,374
+68% +$165K 0.01% 1210
2023
Q4
$266K Buy
+4,969
New +$251K 0.01% 1275
2023
Q3
Sell
-7,135
Closed -$450K 1847
2023
Q2
$450K Buy
+7,135
New +$454K 0.01% 1050
2020
Q4
Sell
-14,386
Closed -$1.06M 1511
2020
Q3
$1.06M Buy
14,386
+2,545
+21% +$204K 0.07% 401
2020
Q2
$869K Sell
11,841
-5,259
-31% -$413K 0.06% 444
2020
Q1
$988K Buy
+17,100
New +$1.19M 0.07% 419
2019
Q4
Sell
-3,513
Closed -$240K 1280
2019
Q3
$240K Buy
+3,513
New +$236K 0.02% 686
2019
Q2
Sell
-5,052
Closed -$424K 1144
2019
Q1
$424K Buy
5,052
+3,179
+170% +$332K 0.03% 630
2018
Q4
$221K Sell
1,873
-2,558
-58% -$296K 0.01% 881
2018
Q3
$534K Sell
4,431
-383
-8% -$47.5K 0.04% 516
2018
Q2
$555K Buy
+4,814
New +$527K 0.04% 507
2017
Q2
Sell
-16,700
Closed -$962K 1196
2017
Q1
$962K Buy
16,700
+13,098
+364% +$782K 0.12% 269
2016
Q4
$220K Buy
+3,602
New +$235K 0.03% 780
2016
Q3
Sell
-5,364
Closed -$299K 1021
2016
Q2
$299K Buy
+5,364
New +$323K 0.04% 666
2016
Q1
Sell
-12,600
Closed -$805K 1195
2015
Q4
$805K Buy
+12,600
New +$817K 0.07% 481

Other funds holding USNA

Trexquant Investment's USNA Position: Q1 2025 in Review

Trexquant Investment sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 11,343 shares — an estimated $407K sold.

Trexquant Investment first reported a position in USNA in Q4 2015 and held it in 18 quarters. The position peaked at $1.89M in Q2 2024. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Trexquant Investment reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Trexquant Investment sold 11,343 Usana Health Sciences shares in Q1 2025, an estimated $407K.
  • Trexquant Investment first reported a position in Usana Health Sciences in Q4 2015 and held it in 18 quarters.
  • Trexquant Investment's Usana Health Sciences position peaked at $1.89M in Q2 2024.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Trexquant Investment's 13F filing for Q1 2025, filed 14 May 2025.